The European Parliament adopted new rules for plants produced with new genomic techniques on 17 June 2026, ending years of debate over how the EU should treat gene-edited crops. The regulation creates two categories with very different obligations. Plants whose genetic changes could have arisen through conventional breeding move out from under the EU's strict GMO rules, while those with more complex modifications stay fully within them.
The shift is fundamental. For the first time, the EU will regulate a plant based on its final genetic makeup rather than the technique used to create it. The previous framework, written in 2001 before these techniques existed, treated every gene-edited plant as a genetically modified organism, regardless of how small the change was.
What new genomic techniques are
New genomic techniques, or NGTs, are a set of breeding tools developed over the past two decades that alter a plant's own DNA with more precision and speed than conventional crossing. The regulation covers two of them: targeted mutagenesis, which induces changes at precise points in the genome without inserting any foreign genetic material, and cisgenesis, which introduces genetic material only from a plant the crop could naturally cross with.
Both differ from transgenesis, the technique behind conventional GMOs, which inserts genes from species that could never interbreed with the plant. Transgenic plants and the application of NGTs to animals or microorganisms are not covered by the new rules and stay under existing GMO legislation.
The distinction matters because the genetic outcomes of targeted mutagenesis and cisgenesis can be identical to what a breeder would achieve through years of crossing and selection, but achieved far more quickly. Products already on the market outside the EU include low-gluten wheat, pathogen-resistant potatoes, and drought-tolerant maize.
The regulation also rests on an older precedent. Random mutagenesis, which exposes seeds to radiation or chemicals to trigger mutations, has been part of conventional breeding since the mid-twentieth century and has been exempt from GMO rules since 1990, even though it scatters far more unintended changes through the genome than targeted editing does. Bringing the newer, more precise techniques under conventional treatment follows the same logic, and it puts into practice the shift to regulating a plant by its result rather than its method. That precision, and how few unintended changes the techniques leave behind, is also the basis for the argument that NGT-1 crops are as safe as conventionally bred ones.
How the two categories differ
The regulation groups NGT plants into two categories based on the extent of their genetic changes.
| Feature | NGT-1 plants | NGT-2 plants |
| Genetic change | Limited changes that could occur through conventional breeding | More extensive or complex modifications |
| Regulatory status | Treated like conventional plants after a verification procedure | Remain under existing GMO legislation |
| Risk assessment | Not required | Required before authorisation and commercialisation |
| Labelling | Seed and reproductive material labelled NGT-1; varieties listed in a public EU database | Full GMO traceability and labelling |
| Member state opt-out | No | Yes, countries may restrict or prohibit cultivation even if EU-authorised |
Source: European Parliament and European Commission, new genomic techniques regulation, 17 June 2026.
A condition Parliament insisted on shapes the boundary of the first category. Plants engineered for herbicide tolerance, or to produce their own insecticidal substances, cannot qualify as NGT-1 regardless of how limited the genetic change is. Those traits keep a plant in the more strictly regulated category.
What it means for farmers and breeders
The practical effect is that NGT-1 seed will reach the market through the same route as conventional seed, without the risk assessment, authorisation, and GMO labelling that made gene-edited crops commercially impractical in the EU. Breeders, particularly small and medium enterprises, gain access to faster development cycles at lower cost. The stated aim is to give European farmers tools to develop crops that resist drought, pests, and disease and require fewer inputs.
That goal connects the regulation to wider work on resilience. The kind of traits NGTs are meant to deliver, such as pest and disease resistance, overlap with the breeding and biotechnology approaches covered in our guide to climate-resilient crops, and with the reduced-pesticide objectives behind integrated pest management. NGT-bred resistance is positioned as another tool in that direction rather than a replacement for agronomic practices.
Seed labelling preserves the farmer's ability to choose. Every bag of NGT-1 seed must carry the NGT-1 label, and the varieties appear in a public database, so a grower who wants to avoid them can.
Organic farming stays NGT-free
No NGTs of either category will be permitted in organic production. The regulation does include one practical allowance: the technically unavoidable presence of an NGT-1 plant in an organic crop will not, on its own, constitute non-compliance. The Commission is to assess whether the rules create administrative, economic, or practical burdens for organic operators, including effects on how organic producers and their customers perceive the sector.
Patents and farmers' rights
NGT plants can be patented, which raised concerns that a few large companies could lock up the technology. Traits or sequences that occur in nature or are produced by biological means cannot be patented. Beyond that, Parliament added safeguards intended to prevent market concentration and to keep the techniques affordable and fairly accessible, including measures to ensure farmers keep the right to save and replant their seed. The framework also requires transparency and monitoring of patents linked to NGT plants.
Sustainability monitoring
To steer the technology toward genuinely useful traits rather than purely commercial ones, the regulation makes monitoring of sustainability impacts mandatory. The Commission will run a program tracking the economic, environmental, and social effects of NGT plants and products once they are on the market, which feeds future evaluation of how the rules are working.
When the rules take effect
The regulation enters into force 20 days after publication in the EU Official Journal and applies two years after that. The text was provisionally agreed between Parliament and Council in December 2025, and the 17 June 2026 vote confirmed it. The two-year gap gives breeders, seed companies, national authorities, and the organic sector time to prepare for the verification procedures, labelling systems, and databases the framework requires.
The rules apply equally to plants developed in the EU and to imports, which aligns the EU more closely with trading partners that already allow gene-edited crops. Several NGT products are in advanced development or already sold outside the bloc, and the new framework sets the terms on which they can enter the European market.
References
- European Parliament. (2026). New genomic techniques for plants to boost innovation in sustainable agriculture. Press release, 17 June 2026.
- European Commission, DG Health and Food Safety. (2026). Legislation for plants obtained by new genomic techniques.
- European Commission. (2026). New genomic techniques in a nutshell. Factsheet, doi:10.2875/4672636.







